Egypt’s Eva Pharma to export COVID-19 drug remdesivir to India

  • Date: 10-May-2021
  • Source: Zawya
  • Sector:Economy
  • Country:Egypt
  • Who else needs to know?

Egypt’s Eva Pharma to export COVID-19 drug remdesivir to India

CAIRO- Egypt's Eva Pharma on Monday signed an agreement to provide India with 300,000 doses of remdesivir, used in the treatment of COVID-19, the company said in a statement. The agreement, which was signed at the Indian embassy in Cairo, is aimed at helping India combat a surge in infections which has overwhelmed the health system and held close to record daily highs on Monday. Eva Pharma, a generic drugmaker established in 1997, said in June 2020 it had received a licence from Gilead Sciences Inc to make remdesivir in Egypt and distribute it in 127 countries. The drug targets moderate to severe cases of COVID-19 in intensive care who require oxygen. Eva Pharma didn't disclose the deal's value. (Reporting by Ehab Farouk; Writing by Mahmoud Mourad; Editing by Nick Macfie) (([email protected];))